The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders 16/11/2018 Artículos
The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999-2007 16/11/2018 Artículos
The impact of parent advocacy groups, the Internet, and social networking on rare diseases: the IDEA League and IDEA League United Kingdom example 16/11/2018 Artículos
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 16/11/2018 Artículos
The contribution of rare diseases to understanding the epidemiology of neurodevelopmental disabilities 16/11/2018 Artículos
The creation of the international thymic malignancies interest group as a model for rare diseases 16/11/2018 Artículos
Tackling rare diseases at European level: why do we need a harmonized framework? 16/11/2018 Artículos
